Archean Chemical Industries Reports 30% Revenue Growth in Q1, Driven by Strong Industrial Salt and Bromine Performance
Archean Chemical Industries Limited reported a 30% year-on-year revenue growth to INR 2,915.00 million in Q1. EBITDA reached INR 958.00 million with a 33% margin. Industrial Salt contributed 70% of revenue, while Elemental Bromine accounted for 30%. The company maintains its position as India's largest exporter of Industrial Salt and manufacturer of Elemental Bromine. Strategic developments include successful pilot trials for Sulphate of Potash, commencement of trial runs for Oren Hydrocarbon, land acquisition for a semiconductor project, and investment in energy storage business. The company remains debt-free and anticipates favorable business conditions in upcoming quarters.

*this image is generated using AI for illustrative purposes only.
Archean Chemical Industries Limited , a leading specialty marine chemical manufacturer, has reported a robust financial performance for the first quarter, with significant growth in revenue and steady margins.
Financial Highlights
- Total revenue for Q1 stood at INR 2,915.00 million on a standalone basis, representing a 30% year-on-year growth.
- EBITDA reached INR 958.00 million, with a healthy margin of 33%.
- Net profit for the quarter was INR 518.50 million.
Segment Performance
Industrial Salt
- Contributed approximately 70% of total revenue at INR 1,940.00 million.
- Sales volume maintained at 1.1 million tons.
- Archean Chemical Industries remains India's largest exporter of Industrial Salt.
Elemental Bromine
- Accounted for about 30% of total revenue at INR 840.00 million.
- Sales volume reached 4,054 tons.
- The company maintains its position as India's largest manufacturer and exporter of Elemental Bromine.
Bromine Derivatives
- Operations are running at 30-40% capacity utilization.
- Contributed INR 230.00 million in revenue.
- Clear brine fluids and catalysts for Purified Terephthalic Acid (PTA) synthesis were key contributors.
Strategic Developments
Sulphate of Potash (SOP):
- Pilot trials have been successful.
- Plant scale trials are expected in the coming quarters.
- Meaningful contributions anticipated in the second half.
Oren Hydrocarbon (renamed Idealis Mudchemie):
- Trial runs have commenced in two units.
- Product qualification has begun with positive customer acceptance.
- Commercial production expected to start soon.
Semiconductor Project:
- Land acquisition completed in Odisha.
- RFQs tendered for project management office.
- Groundwork expected to commence post-monsoon.
Energy Storage Business:
- Acquired 18.14% stake in Offgrid Energy Labs, a zinc-bromide battery innovator.
- Pilot site finalized and vendor selection completed for the UK pilot plant.
Market Outlook
Ranjit Pendurthi, Managing Director, commented on the market conditions: "We are witnessing mixed trends across the chemical industry with early signs of recovery in select segments. Inquiry levels are steadily improving, indicating a more favorable business environment in the coming quarters and years ahead."
The company maintains a positive outlook, supported by long-term contracts and strong customer relationships. Despite global challenges, Archean Chemical Industries remains focused on operational efficiency and strategic growth initiatives.
Financial Position
The company continues to maintain a debt-free status, backed by a robust balance sheet and disciplined capital allocation. This financial strength provides strategic flexibility for investing in long-term growth opportunities.
As Archean Chemical Industries continues to navigate the evolving market landscape, its diversified product portfolio and strong market position are expected to drive sustained growth in the coming quarters.
Historical Stock Returns for Archean Chemical Industries
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
-4.37% | -6.17% | -1.23% | +30.14% | -17.14% | +43.02% |